Call will take place on Wednesday, September 3, 2014 at 10 am ET
DELRAY BEACH, Fla.--(BUSINESS WIRE)--
VeriTeQ Corporation (“VeriTeQ”) (OTC Markets: VTEQ), a provider of
implantable medical device identification and radiation dose measurement
technologies, announced today that it will host a conference call on
Wednesday, September 3, 2014, at 10 a.m. ET, to update investors on the
business and other recent events.
Interested participants should call (800) 219-3192 within the United
States or (617) 597-5412 internationally, and use passcode 71640596#.
For those unable to participate in the conference call, a replay will be
available on September 3, 2014 at 11:59 p.m. ET for seven days. For the
replay, dial (888) 286-8010 within the United States or (617) 801-6888
internationally, and use passcode 57571260.
VeriTeQ develops innovative, proprietary RFID technologies for
implantable medical device identification, and dosimeter technologies
for use in radiation therapy treatment. VeriTeQ offers the world's first
FDA cleared RFID microchip technology that can be used to identify
implantable medical devices, in vivo, on demand, at the point of care.
VeriTeQ's dosimeters provide patient safety mechanisms while measuring
and recording the dose of radiation delivered to a patient in real time.
For more information on VeriTeQ, please visit www.veriteqcorp.com.
Statements in this press release about our future expectations
constitute "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private
Litigation Reform Act of 1995. Such forward-looking statements involve
risks and uncertainties and are subject to change at any time, and our
actual results could differ materially from expected results. Additional
information about these and other factors may be described in VeriTeQ’s
Form 10-K, filed on April 15, 2014, and Forms 10-Q, filed on August 19,
2014, May 14, 2014, November 14, 2013, and future filings with the
Securities and Exchange Commission The Company undertakes no obligation
to update or release any revisions to these forward-looking statements
to reflect events or circumstances after the date of this statement or
to reflect the occurrence of unanticipated events, except as required by
Allison Tomek, 561-846-7003
Brendan Hopkins, 1-800-RED-CHIP (733-2447) Ext 134
Source: VeriTeQ Corporation